<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35066640</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>17</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>19</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1436-6215</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>61</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>European journal of nutrition</Title>
          <ISOAbbreviation>Eur J Nutr</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Differential impact of cold and hot tea extracts on tyrosine phosphatases regulating insulin receptor activity: a focus on PTP1B and LMW-PTP.</ArticleTitle>
        <Pagination>
          <StartPage>1905</StartPage>
          <EndPage>1918</EndPage>
          <MedlinePgn>1905-1918</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00394-021-02776-w</ELocationID>
        <Abstract>
          <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The impact of tea constituents on the insulin-signaling pathway as well as their antidiabetic activity are still debated questions. Previous studies suggested that some tea components act as Protein Tyrosine Phosphatase 1B (PTP1B) inhibitors. However, their nature and mechanism of action remain to be clarified. This study aims to evaluate the effects of both tea extracts and some of their constituents on two main negative regulators of the insulin-signaling pathway, Low-Molecular-Weight Protein Tyrosine Phosphatase (LMW-PTP) and PTP1B.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">The effects of cold and hot tea extracts on the enzyme activity were evaluated through in vitro assays. Active components were identified using gas chromatography-mass spectrometry (GC-MS) analysis. Finally, the impact of both whole tea extracts and specific active tea components on the insulin-signaling pathway was evaluated in liver and muscle cells.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">We found that both cold and hot tea extracts inhibit LMW-PTP and PTP1B, even if with a different mechanism of action. We identified galloyl moiety-bearing catechins as the tea components responsible for this inhibition. Specifically, kinetic and docking analyses revealed that epigallocatechin gallate (EGCG) is a mixed-type non-competitive inhibitor of PTP1B, showing an IC<sub>50</sub> value in the nanomolar range. Finally, in vitro assays confirmed that EGCG acts as an insulin-sensitizing agent and that the chronic treatment of liver cells with tea extracts results in an enhancement of the insulin receptor levels and insulin sensitivity.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Altogether, our data suggest that tea components are able to regulate both protein levels and activation status of the insulin receptor by modulating the activity of PTP1B.</AbstractText>
          <CopyrightInformation>© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Genovese</LastName>
            <ForeName>Massimo</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Viale Morgagni 50, 50134, Florence, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Luti</LastName>
            <ForeName>Simone</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Viale Morgagni 50, 50134, Florence, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pardella</LastName>
            <ForeName>Elisa</ForeName>
            <Initials>E</Initials>
            <Identifier Source="ORCID">0000-0001-5655-6428</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Viale Morgagni 50, 50134, Florence, Italy. elisa.pardella@unifi.it.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vivoli-Vega</LastName>
            <ForeName>Mirella</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Viale Morgagni 50, 50134, Florence, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pazzagli</LastName>
            <ForeName>Luigia</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Viale Morgagni 50, 50134, Florence, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Parri</LastName>
            <ForeName>Matteo</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Viale Morgagni 50, 50134, Florence, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Caselli</LastName>
            <ForeName>Anna</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Viale Morgagni 50, 50134, Florence, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cirri</LastName>
            <ForeName>Paolo</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Viale Morgagni 50, 50134, Florence, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Paoli</LastName>
            <ForeName>Paolo</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Viale Morgagni 50, 50134, Florence, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>01</Month>
          <Day>23</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Eur J Nutr</MedlineTA>
        <NlmUniqueID>100888704</NlmUniqueID>
        <ISSNLinking>1436-6207</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D004791">Enzyme Inhibitors</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007328">Insulin</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010936">Plant Extracts</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D013662">Tea</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.10.1</RegistryNumber>
          <NameOfSubstance UI="D011972">Receptor, Insulin</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.1.3.48</RegistryNumber>
          <NameOfSubstance UI="C516607">PTPN1 protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.1.3.48</RegistryNumber>
          <NameOfSubstance UI="D054562">Protein Tyrosine Phosphatase, Non-Receptor Type 1</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.1.3.48</RegistryNumber>
          <NameOfSubstance UI="D017027">Protein Tyrosine Phosphatases</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D004791" MajorTopicYN="N">Enzyme Inhibitors</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007333" MajorTopicYN="Y">Insulin Resistance</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010936" MajorTopicYN="N">Plant Extracts</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D054562" MajorTopicYN="N">Protein Tyrosine Phosphatase, Non-Receptor Type 1</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017027" MajorTopicYN="Y">Protein Tyrosine Phosphatases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011972" MajorTopicYN="Y">Receptor, Insulin</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013662" MajorTopicYN="Y">Tea</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Epigallocatechin gallate</Keyword>
        <Keyword MajorTopicYN="N">Insulin resistance</Keyword>
        <Keyword MajorTopicYN="N">PTP1B inhibitors</Keyword>
        <Keyword MajorTopicYN="N">Tea extracts</Keyword>
        <Keyword MajorTopicYN="N">Type 2 diabetes</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>2</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>23</Day>
          <Hour>20</Hour>
          <Minute>37</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35066640</ArticleId>
        <ArticleId IdType="doi">10.1007/s00394-021-02776-w</ArticleId>
        <ArticleId IdType="pii">10.1007/s00394-021-02776-w</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Saeedi P, Petersohn I, Salpea P, et al (2019) Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract 157:107843. https://doi.org/10.1016/j.diabres.2019.107843</Citation>
        </Reference>
        <Reference>
          <Citation>Zheng Y, Ley SH, Hu FB (2018) Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol 14:88–98. https://doi.org/10.1038/nrendo.2017.151</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrendo.2017.151</ArticleId>
            <ArticleId IdType="pubmed">29219149</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu Y, Ding Y, Tanaka Y, Zhang W (2014) Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention. Int J Med Sci 11:1185–1200. https://doi.org/10.7150/ijms.10001</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7150/ijms.10001</ArticleId>
            <ArticleId IdType="pubmed">25249787</ArticleId>
            <ArticleId IdType="pmc">4166864</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DeFronzo RA (2009) From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58:773–795. https://doi.org/10.2337/db09-9028</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db09-9028</ArticleId>
            <ArticleId IdType="pubmed">19336687</ArticleId>
            <ArticleId IdType="pmc">2661582</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meneses M, Silva B, Sousa M et al (2015) Antidiabetic drugs: mechanisms of action and potential outcomes on cellular metabolism. Curr Pharm Des 21:3606–3620. https://doi.org/10.2174/1381612821666150710145753</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/1381612821666150710145753</ArticleId>
            <ArticleId IdType="pubmed">26166608</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bailey CJ, Day C (2018) Treatment of type 2 diabetes: future approaches. Br Med Bull 126:123–137. https://doi.org/10.1093/brimed/ldy013</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/brimed/ldy013</ArticleId>
            <ArticleId IdType="pubmed">29897499</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maffi P, Secchi A (2017) The Burden of Diabetes: Emerging Data. In: Developments in Ophthalmology. pp 1–5</Citation>
        </Reference>
        <Reference>
          <Citation>Ley SH, Hamdy O, Mohan V, Hu FB (2014) Prevention and management of type 2 diabetes: dietary components and nutritional strategies. Lancet 383:1999–2007. https://doi.org/10.1016/S0140-6736(14)60613-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(14)60613-9</ArticleId>
            <ArticleId IdType="pubmed">24910231</ArticleId>
            <ArticleId IdType="pmc">4751088</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karri S, Sharma S, Hatware K, Patil K (2019) Natural anti-obesity agents and their therapeutic role in management of obesity: a future trend perspective. Biomed Pharmacother 110:224–238. https://doi.org/10.1016/j.biopha.2018.11.076</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biopha.2018.11.076</ArticleId>
            <ArticleId IdType="pubmed">30481727</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goyal S, Gupta N, Chatterjee S, Nimesh S (2016) Natural plant extracts as potential therapeutic agents for the treatment of cancer. Curr Top Med Chem 17:96–106. https://doi.org/10.2174/1568026616666160530154407</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/1568026616666160530154407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dou QP (2019) Tea in health and disease. Nutrients 11:929. https://doi.org/10.3390/nu11040929</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/nu11040929</ArticleId>
            <ArticleId IdType="pmc">6520965</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fu Q-Y, Li Q-S, Lin X-M et al (2017) Antidiabetic effects of tea. Molecules 22:849. https://doi.org/10.3390/molecules22050849</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/molecules22050849</ArticleId>
            <ArticleId IdType="pmc">6154530</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ma J, Li Z, Xing S et al (2011) Tea contains potent inhibitors of tyrosine phosphatase PTP1B. Biochem Biophys Res Commun 407:98–102. https://doi.org/10.1016/j.bbrc.2011.02.116</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbrc.2011.02.116</ArticleId>
            <ArticleId IdType="pubmed">21371422</ArticleId>
            <ArticleId IdType="pmc">3070786</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuban-Jankowska A, Kostrzewa T, Musial C, et al (2020) Green Tea Catechins Induce Inhibition of PTP1B Phosphatase in Breast Cancer Cells with Potent Anti-Cancer Properties: In Vitro Assay, Molecular Docking, and Dynamics Studies. Antioxidants 9:1208. https://doi.org/10.3390/antiox9121208</Citation>
        </Reference>
        <Reference>
          <Citation>Eleftheriou P, Geronikaki A, Petrou A (2019) PTP1b inhibition, a promising approach for the treatment of diabetes type II. Curr Top Med Chem 19:246–263. https://doi.org/10.2174/1568026619666190201152153</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/1568026619666190201152153</ArticleId>
            <ArticleId IdType="pubmed">30714526</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stanford SM, Aleshin AE, Zhang V et al (2017) Diabetes reversal by inhibition of the low-molecular-weight tyrosine phosphatase. Nat Chem Biol 13:624–632. https://doi.org/10.1038/nchembio.2344</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nchembio.2344</ArticleId>
            <ArticleId IdType="pubmed">28346406</ArticleId>
            <ArticleId IdType="pmc">5435566</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perva-Uzunalić A, Škerget M, Knez Ž et al (2006) Extraction of active ingredients from green tea (Camellia sinensis): extraction efficiency of major catechins and caffeine. Food Chem 96:597–605. https://doi.org/10.1016/j.foodchem.2005.03.015</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.foodchem.2005.03.015</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lori G, Cecchi L, Mulinacci N et al (2019) Honey extracts inhibit PTP1B, upregulate insulin receptor expression, and enhance glucose uptake in human HepG2 cells. Biomed Pharmacother 113:108752. https://doi.org/10.1016/j.biopha.2019.108752</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biopha.2019.108752</ArticleId>
            <ArticleId IdType="pubmed">30927676</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ottanà R, Paoli P, Cappiello M, et al (2021) In Search for Multi-Target Ligands as Potential Agents for Diabetes Mellitus and Its Complications-A Structure-Activity Relationship Study on Inhibitors of Aldose Reductase and Protein Tyrosine Phosphatase 1B. Molecules 26:. https://doi.org/10.3390/molecules26020330</Citation>
        </Reference>
        <Reference>
          <Citation>Morris GM, Huey R, Lindstrom W et al (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30:2785–2791. https://doi.org/10.1002/jcc.21256</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcc.21256</ArticleId>
            <ArticleId IdType="pubmed">19399780</ArticleId>
            <ArticleId IdType="pmc">2760638</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pettersen EF, Goddard TD, Huang CC et al (2004) UCSF Chimera?A visualization system for exploratory research and analysis. J Comput Chem 25:1605–1612. https://doi.org/10.1002/jcc.20084</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcc.20084</ArticleId>
            <ArticleId IdType="pubmed">15264254</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wallace AC, Laskowski RA, Thornton JM (1995) LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. "Protein Eng Des Sel 8:127–134. https://doi.org/10.1093/protein/8.2.127</Citation>
        </Reference>
        <Reference>
          <Citation>Laskowski RA, Swindells MB (2011) LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model 51:2778–2786. https://doi.org/10.1021/ci200227u</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/ci200227u</ArticleId>
            <ArticleId IdType="pubmed">21919503</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shibata E, Kanno T, Tsuchiya A et al (2013) Free fatty acids inhibit protein tyrosine phosphatase 1B and activate Akt. Cell Physiol Biochem 32:871–879. https://doi.org/10.1159/000354489</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000354489</ArticleId>
            <ArticleId IdType="pubmed">24107614</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao BT, Nguyen DH, Le DD et al (2018) Protein tyrosine phosphatase 1B inhibitors from natural sources. Arch Pharm Res 41:130–161. https://doi.org/10.1007/s12272-017-0997-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12272-017-0997-8</ArticleId>
            <ArticleId IdType="pubmed">29214599</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Puius YA, Zhao Y, Sullivan M et al (1997) Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: a paradigm for inhibitor design. Proc Natl Acad Sci USA 94:13420–13425. https://doi.org/10.1073/pnas.94.25.13420</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.94.25.13420</ArticleId>
            <ArticleId IdType="pubmed">9391040</ArticleId>
            <ArticleId IdType="pmc">28320</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tuomilehto J, Lindström J, Eriksson JG et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350. https://doi.org/10.1056/NEJM200105033441801</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJM200105033441801</ArticleId>
            <ArticleId IdType="pubmed">11333990</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mirmiran P (2014) Functional foods-based diet as a novel dietary approach for management of type 2 diabetes and its complications: a review. World J Diabetes 5:267–281. https://doi.org/10.4239/wjd.v5.i3.267</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4239/wjd.v5.i3.267</ArticleId>
            <ArticleId IdType="pubmed">24936248</ArticleId>
            <ArticleId IdType="pmc">4058731</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Serafini M, Del Rio D, Yao DN, et al (2011) Health Benefits of Tea</Citation>
        </Reference>
        <Reference>
          <Citation>Xing L, Zhang H, Qi R et al (2019) Recent advances in the understanding of the health benefits and molecular mechanisms associated with green tea polyphenols. J Agric Food Chem 67:1029–1043. https://doi.org/10.1021/acs.jafc.8b06146</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/acs.jafc.8b06146</ArticleId>
            <ArticleId IdType="pubmed">30653316</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang R, Zhou W, Jiang X (2008) Reaction Kinetics of degradation and epimerization of epigallocatechin gallate (EGCG) in aqueous system over a wide temperature range. J Agric Food Chem 56:2694–2701. https://doi.org/10.1021/jf0730338</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/jf0730338</ArticleId>
            <ArticleId IdType="pubmed">18361498</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fan F-Y, Shi M, Nie Y et al (2016) Differential behaviors of tea catechins under thermal processing: formation of non-enzymatic oligomers. Food Chem 196:347–354. https://doi.org/10.1016/j.foodchem.2015.09.056</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.foodchem.2015.09.056</ArticleId>
            <ArticleId IdType="pubmed">26593500</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuzuhara T, Suganuma M, Fujiki H (2008) Green tea catechin as a chemical chaperone in cancer prevention. Cancer Lett 261:12–20. https://doi.org/10.1016/j.canlet.2007.10.037</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.canlet.2007.10.037</ArticleId>
            <ArticleId IdType="pubmed">18068893</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wiesmann C, Barr KJ, Kung J et al (2004) Allosteric inhibition of protein tyrosine phosphatase 1B. Nat Struct Mol Biol 11:730–737. https://doi.org/10.1038/nsmb803</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nsmb803</ArticleId>
            <ArticleId IdType="pubmed">15258570</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clifford MN, van der Hooft JJ, Crozier A (2013) Human studies on the absorption, distribution, metabolism, and excretion of tea polyphenols. Am J Clin Nutr 98:1619S-1630S. https://doi.org/10.3945/ajcn.113.058958</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3945/ajcn.113.058958</ArticleId>
            <ArticleId IdType="pubmed">24172307</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen Y-K, Cheung C, Reuhl KR et al (2011) Effects of green tea polyphenol (−)-epigallocatechin-3-gallate on newly developed high-fat/western-style diet-induced obesity and metabolic syndrome in mice. J Agric Food Chem 59:11862–11871. https://doi.org/10.1021/jf2029016</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/jf2029016</ArticleId>
            <ArticleId IdType="pubmed">21932846</ArticleId>
            <ArticleId IdType="pmc">3243651</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bose M, Lambert JD, Ju J et al (2008) The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat–fed mice. J Nutr 138:1677–1683. https://doi.org/10.1093/jn/138.9.1677</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jn/138.9.1677</ArticleId>
            <ArticleId IdType="pubmed">18716169</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Molinaro A, Becattini B, Solinas G (2020) Insulin signaling and glucose metabolism in different hepatoma cell lines deviate from hepatocyte physiology toward a convergent aberrant phenotype. Sci Rep 10:12031. https://doi.org/10.1038/s41598-020-68721-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-020-68721-9</ArticleId>
            <ArticleId IdType="pubmed">32694512</ArticleId>
            <ArticleId IdType="pmc">7374613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wong CY, Al-Salami H, Dass CR (2020) C2C12 cell model: its role in understanding of insulin resistance at the molecular level and pharmaceutical development at the preclinical stage. J Pharm Pharmacol 72:1667–1693. https://doi.org/10.1111/jphp.13359</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jphp.13359</ArticleId>
            <ArticleId IdType="pubmed">32812252</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Collins QF, Liu H-Y, Pi J et al (2007) Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 5′-AMP-activated protein kinase. J Biol Chem 282:30143–30149. https://doi.org/10.1074/jbc.M702390200</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M702390200</ArticleId>
            <ArticleId IdType="pubmed">17724029</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolfram S, Raederstorff D, Preller M et al (2006) Epigallocatechin gallate supplementation alleviates diabetes in rodents. J Nutr 136:2512–2518. https://doi.org/10.1093/jn/136.10.2512</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jn/136.10.2512</ArticleId>
            <ArticleId IdType="pubmed">16988119</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crettaz M, Kahn CR (1984) Insulin receptor regulation and desensitization in rat hepatoma cells: concomitant changes in receptor number and in binding affinity. Diabetes 33:477–485. https://doi.org/10.2337/diab.33.5.477</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/diab.33.5.477</ArticleId>
            <ArticleId IdType="pubmed">6144607</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang W-M, Jeong H-J, Park S-Y, Lee W (2014) Saturated fatty acid-induced miR-195 impairs insulin signaling and glycogen metabolism in HepG2 cells. FEBS Lett 588:3939–3946. https://doi.org/10.1016/j.febslet.2014.09.006</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.febslet.2014.09.006</ArticleId>
            <ArticleId IdType="pubmed">25240198</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang W-M, Jeong H-J, Park S-W, Lee W (2015) Obesity-induced miR-15b is linked causally to the development of insulin resistance through the repression of the insulin receptor in hepatocytes. Mol Nutr Food Res 59:2303–2314. https://doi.org/10.1002/mnfr.201500107</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/mnfr.201500107</ArticleId>
            <ArticleId IdType="pubmed">26179126</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Y, Zhong Y, Cheng Q, et al (2020) miR-378b Regulates Insulin Sensitivity by Targeting Insulin Receptor and p110α in Alcohol-Induced Hepatic Steatosis. Front Pharmacol 11:. https://doi.org/10.3389/fphar.2020.00717</Citation>
        </Reference>
        <Reference>
          <Citation>Na B, Nguyen P-H, Zhao B-T et al (2016) Protein tyrosine phosphatase 1B (PTP1B) inhibitory activity and glucosidase inhibitory activity of compounds isolated from Agrimonia pilosa. Pharm Biol 54:474–480. https://doi.org/10.3109/13880209.2015.1048372</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/13880209.2015.1048372</ArticleId>
            <ArticleId IdType="pubmed">26084800</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang J, Sasaki T, Li W et al (2018) Identification of caffeoylquinic acid derivatives as natural protein tyrosine phosphatase 1B inhibitors from Artemisia princeps. Bioorg Med Chem Lett 28:1194–1197. https://doi.org/10.1016/j.bmcl.2018.02.052</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bmcl.2018.02.052</ArticleId>
            <ArticleId IdType="pubmed">29525218</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lipchock JM, Hendrickson HP, Douglas BB et al (2017) Characterization of Protein tyrosine phosphatase 1B inhibition by chlorogenic acid and cichoric acid. Biochemistry 56:96–106. https://doi.org/10.1021/acs.biochem.6b01025</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/acs.biochem.6b01025</ArticleId>
            <ArticleId IdType="pubmed">27959494</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dixit M, Tripathi BK, Srivastava AK, Goel A (2005) Synthesis of functionalized acetophenones as protein tyrosine phosphatase 1B inhibitors. Bioorg Med Chem Lett 15:3394–3397. https://doi.org/10.1016/j.bmcl.2005.05.024</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bmcl.2005.05.024</ArticleId>
            <ArticleId IdType="pubmed">15951172</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haftchenary S, Jouk AO, Aubry I et al (2015) Identification of bidentate salicylic acid inhibitors of PTP1B. ACS Med Chem Lett 6:982–986. https://doi.org/10.1021/acsmedchemlett.5b00171</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/acsmedchemlett.5b00171</ArticleId>
            <ArticleId IdType="pubmed">26396684</ArticleId>
            <ArticleId IdType="pmc">4569880</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shrestha S, Bhattarai BR, Lee K-H, Cho H (2007) Mono- and disalicylic acid derivatives: PTP1B inhibitors as potential anti-obesity drugs. Bioorg Med Chem 15:6535–6548. https://doi.org/10.1016/j.bmc.2007.07.010</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bmc.2007.07.010</ArticleId>
            <ArticleId IdType="pubmed">17692525</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barik SK, Russell WR, Dehury B et al (2019) Dietary phenolics other than anthocyanins inhibit PTP1B; an in vitro and in silico validation. Proc Nutr Soc 78:E25. https://doi.org/10.1017/S0029665119000296</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/S0029665119000296</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
